The goal is to ensure that 60 percent of the vaccines used in Africa are produced within its borders by the year 2040, a move designed to dramatically reduce the continent’s reliance on imports.
Currently, Africa faces a significant shortfall in vaccine production, manufacturing a mere one percent of the vaccines it needs. This dependence limits the ability of African nations to effectively and swiftly respond to disease outbreaks, as highlighted by the recent global health crises.
Efforts to bridge this gap are gaining traction, with the Africa Centres for Disease Control and Prevention (Africa CDC) playing a central role. Kevin Irandagiye, Technical Communications Officer at Africa CDC’s Platform for Harmonised African Health Products Manufacturing (PHAHM), shared this ambitious plan during a health journalism workshop held in Ethiopia. He noted that three companies located in South Africa and Senegal are projected to commence production of eight different vaccines by the year 2030, marking a crucial step towards the 2040 target.
The focus of this manufacturing push will be on addressing five major disease areas that pose a significant health burden across Africa: diabetes, HIV, malaria, neglected tropical diseases (NTDs), and tuberculosis.
The statistics underscore the urgency of this initiative. In 2022 alone, the continent recorded 600,000 new HIV infections, nearly half of the global total. Malaria cases reached 230 million in the same period, accounting for a staggering 94 percent of worldwide infections. Furthermore, cases of NTDs saw a concerning rise to 36.2 percent, up from 25.6 percent in 2000, and an estimated 700,000 individuals with tuberculosis went undiagnosed in 2022.
“At Africa CDC, we are working to ensure these vaccines meet demand as part of our journey towards the 2040 target,” affirmed Irandagiye, emphasizing the commitment to achieving vaccine self-sufficiency.
A recent report from the World Health Organisation (WHO) highlights the profound impact of vaccination efforts in Africa over the past five decades, estimating that approximately 51.2 million lives have been saved across the continent. Key achievements include a significant decline in measles-related deaths, with an estimated 19.5 million deaths prevented in the last 22 years.
Meningitis-related deaths also saw a substantial reduction, dropping by as much as 39 percent in 2019 compared to 2000. Furthermore, the African region was declared free of indigenous wild poliovirus in 2022, a testament to years of dedicated efforts.
This new push for local vaccine manufacturing signifies a strategic move by the African Union to bolster the continent’s health security, reduce its reliance on external supplies, and ensure a more robust and timely response to current and future health challenges.
